The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

COVID-19 treatment called into question after major study In a nutshell A major study of 1.6 million seniors found that ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

The authors compared outcomes among adults just under 70 years who were not prescribed Paxlovid to those who were given the ...

The all-or-nothing strategy has landed the ‘pride of the pharmaceutical industry' in a situation that deteriorated rapidly.

A new analysis of health data from Ontario, Canada, suggests that nirmatrelvir-ritonavir (Paxlovid) may provide limited benefit for vaccinated older adults with COVID-19, despite its previously proven ...

Most people will recover from viruses like the flu, COVID, and RSV without medical care, but some patients might need a trip ...

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

Bay Area News Group: Berkeley Man Sues Kaiser Permanente, Accuses Medical Assistant Of Sexual Assault During Cancer Surgery A Kaiser Permanente patient filed a lawsuit last week against the ...